|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.
The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by Credit Suisse on 2021-03-22. The analyst firm set a price target for 58.00 expecting EDIT to rise to within 12 months (a possible 37.96% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Editas Medicine (NASDAQ: EDIT) is $42.04 last updated Today at 5:31:56 PM.
There are no upcoming dividends for Editas Medicine.
There is no upcoming split for Editas Medicine.